Navigation Links
Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease
Date:7/29/2008

Gene silencing techniques and induced pluripotent stem cell technology are among the cutting-edge approaches to Parkinson's drug development funded through The Michael J. Fox Foundation's Rapid Response Innovation Awards 2008. As part of its mission to drive transformative treatments and a cure for PD, the Foundation has awarded $1.1 million for 15 high-risk, high-reward Parkinson's disease research projects under the initiative in the first half of the year. Applications are still being accepted, and a total of $2 million in Rapid Response awards is expected by year's end.

Rapid Response helps keep new and novel approaches to Parkinson's disease flowing into the drug development pipeline by allowing researchers to pursue their most exciting ideas in real time. The Foundation accepts Rapid Response proposals on a rolling basis with no deadline, and funding decisions are made within six weeks of application. Awards of up to $75,000 are available for one-year basic, preclinical or clinical research projects in any Parkinson's-relevant arena. The program has met with an enthusiastic response from the research community, both within Parkinson's disease and beyond, since it was first launched in January 2007.

"Rapid Response infuses capital quickly into exciting new ideas that could open up important new avenues of inquiry for Parkinson's disease," said Katie Hood, CEO of The Michael J. Fox Foundation. "Our goal is to provide the funding needed to further 'build the case' for these new concepts, developing the data required before other traditional funding sources can step in."

The program's application process and funding criteria emphasize speed and novelty. Funded projects typically are strong ideas being tested for the first time. Unlike other Foundation initiatives, Rapid Response allows for the submission of applications at any time of year. There is no pre-proposal triage stage, and the standard MJFF application has been shorte
'/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
2. Neuroscientist Michael Gazzaniga awarded Humboldt Prize
3. Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference
4. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
5. American Society for Microbiology honors Michael Bruce Zwick
6. Michael A. Betts, Seasoned Financial Services Executive, Joins CIC Board of Directors
7. W.M. Keck Foundation grant funds reproductive science research
8. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
9. Glenn Foundation for Medical Research commits $5 million to study aging
10. BBVA Foundation Awards for Biodiversity Conservation
11. The Parkinsons Disease Foundation awards $950,000 in seed grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)... die from stroke more than in any other U.S. regio...report by researchers at the University of Alabama... underscores that geographic and racial difference...er stroke death rate. , The data is from UAB,s R...roke (REGARDS) study, which has enrolled more than...
(Date:1/8/2009)...ary history of diatoms -- abundant oceanic plankto...rom the air each year -- needs to be rewritten, ac...st that after a sudden rise in species numbers, di... -- trends that coincided with severe global cooli...of the journal Nature . , The research casts dou...
(Date:1/8/2009)...flood come in rapid succession, the extent of dama...e of those events, according to a new study publis...which focused on tree species common to the Evergl...igher growth rates and were less likely to die whe...an vice versa. The findings could have significant...
(Date:1/8/2009)...national journal that publishes original research ...cular aspects of entomology, plant pathology, viro...cticides, fungicides, herbicides and other biocide...f pests and diseases. , Phytoparasitica also p...reviews. Guest editorials written by reputable sc...
Breaking Biology News(10 mins):'Stroke Belt' deaths tied to non-traditional risk factors 2Decline of carbon-dioxide-gobbling plankton coincided with ancient global cooling 2Sequence matters in droughts and floods 2Springer expands its portfolio in plant sciences with Phytoparasitica 2Nikon Instruments Launches Fully Automated A1 Confocal Laser Microscope Series 2817 1Nikon Instruments Launches Fully Automated A1 Confocal Laser Microscope Series 2817 2Nikon Instruments Launches Fully Automated A1 Confocal Laser Microscope Series 2817 3Nikon Instruments Launches Fully Automated A1 Confocal Laser Microscope Series 2817 4Ventas Enters Agreement to Sell Common Stock 10328 1Ventas Enters Agreement to Sell Common Stock 10328 2Ventas Enters Agreement to Sell Common Stock 10328 3Ventas Enters Agreement to Sell Common Stock 10328 4Ventas Enters Agreement to Sell Common Stock 10328 5BabySupply Info Announces Launch of Website for New Parents 10326 1BabySupply Info Announces Launch of Website for New Parents 10326 2MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling 244 Million 10324 1MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling 244 Million 10324 2MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling 244 Million 10324 3MedeFile Materially Strengthens Balance Sheet Through Equity Financing and Debt Conversion Totaling 244 Million 10324 4
...ithin weeks after a person is infected with the HI...search Center and the Bernard-Nocht Institute appe...S Medicine, researchers report that these memory T...not to return to normal even after years of treatm...been shown to deplete the body’s memory T cells qu...
...ournal Cell Metabolism, published by Cell Press, o... glands of mammals meet the incredible metabolic d...of breast development undoubtedly affect breast ca...ns, the researchers said. , The researchers found ...kt is specifically required for lactating mice to ...
...ealthier lives since the development of highly act...fact, most patients on the drug regimen do so well...s appear to return to pre-HIV levels. But two new ...Diamond AIDS Research Center (ADARC) show that the...und, suggesting the need for additional ways to mo...
...d babblers (Turdoides bicolor) in the Kalahari Des...way in which parent birds can extend the period of...d by Andrew Radford of the University of Cambridge...and appear in the September 5th issue of Current B...own that birds feed their young directly, but it i...
Other Biology News:Early HIV treatment fails to restore memory T cells 2How mammals fuel milk production may have implications for cancer 2How mammals fuel milk production may have implications for cancer 3HIV-1 kills immune cells in the gut that may never bounce back 2HIV-1 kills immune cells in the gut that may never bounce back 3
(Date:1/8/2009)...RIDGE, Mass., Jan. 8 /PRNewswire/ -- The Nano Sc...nced that the Nanotech Conference & Expo 2009 ...wn Convention Center, in Houston, Texas. Now in i...echnology event is expected to attract a community... executives, who will gather to promote advanced r...
(Date:1/8/2009)...N.J., Jan. 8 Ikaria Holdings, Inc....iel Tasse, will present at the 27th Annual JPMorga...2009 at 8:00 a.m., PST. The conference will be he...n San Francisco. , , About Ikaria Holdings, In... biotherapeutics company focused on the developmen...
(Date:1/8/2009)... Jan. 8 /PRNewswire/ - Aegera Therapeutics Inc. an... randomized Phase 2 study of AEG35156, their targe... for multiple oncology indications. , The study, ...omized Study of the X-Linked Inhibitor of Apoptosi...ith Carboplatin/Paclitaxel or the Combination of C...
(Date:1/8/2009)...resentation Scheduled for Wednesday, January 14, 2... SAN CARLOS, Calif., Jan. 8 /PRNewswire-FirstCall/...any developing genetically-targeted therapies for ...nd Nuvelo, Inc. (Nasdaq: NUVO ) today announced ...ecutive officer, will present at the 27th Annual J...
Breaking Biology Technology:NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 2NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 3NSTI Announces the 12th Annual Nanotech Conference & Expo 2009 May 3-7, at the George R. Brown Convention Center in Houston, Texas 4Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference 2Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 2ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 3ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 4ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference 5
...ha, Wis. - GE Healthcare , a unit of General E...ectronic Health Record (EHR) has received certific...m the Certification Commission for Healthcare Inf...nsidered the stamp of approval for providers and a...nctionality, interoperability, and security criter...
...n, Wis. - The legal challenge to stem cell paten...on has escalated the war of words between two sta...ing the other,s financial motivations. , ,The most...ndation , on behalf of the California-based Found...ormal request with the United States Patent and T...
...hland, Wis. - Determining how technology can help...with an honest assessment of what doesn,t make s...medical research institution in its backyard, it s... "hot spot," even if free land and tax incentives ...uding Wisconsin, scrambling to find the right nich...
...ha, Wis. - A product for molecular diagnostics an...ents, thanks to the global distribution capability...ere. , ,As part of a new license agreement, Prodes...assays with light upon extension (LUX) technology ... , ,Prodesse, a developer of multiplex polymerase...
Other Biology Technology:Request to re-examine WARF stem cell patents escalates war of words 2Request to re-examine WARF stem cell patents escalates war of words 3Technology in the Northwoods 2Technology in the Northwoods 3Prodesse joins forces with Invitrogen 2
... The Oxidized LDL Competitive ELISA is based on t...mple competes with a fixed amount of oxidized LDL ...e biotin- labeled specific antibodies. After a was...titive Enzyme-Linked Immunosorbent Assay (ELISA) k...
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture
...a gel piece, we can identify it using MALDI-TOF/TO...produce a mixture of peptides. The molecular weigh...TOF, and the amino acid sequences of the top 10 pe...y MALDI-TOF/TOF. The masses and sequences will be ...
EZ-Tn5™ Transposase is designed for use with our pMOD™ series of vectors as well as any EZ-Tn5™ transposon system.
Biology Products: